Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTPa-IPV combination vaccine versus separate DTPa and IPV vaccines in healthy infants
2015-001508-71Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diphtheria, Tetanus, pertussis and 1 more comparing Combined DTPa-IPV vaccine with Separate DTPa and IPV vaccines (2 arms).
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccinediphtheria toxoid + tetanus toxoid + acellular pertussistrivalent inactivated polio vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on 2015-001508-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001508-71.